Upendra Wickrema Singhe – Trademark Portfolio

Entity Type: 01

Upendra Wickrema Singhe holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 30 (Staple Foods) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TEVIVE. The owner is based in Houston, TX.

13902 Charlton Way Dr.

Houston, TX 77077

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Upendra Wickrema Singhe's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

30
Staple Foods (2 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Upendra Wickrema Singhe have?

Upendra Wickrema Singhe has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.

What trademark classes does Upendra Wickrema Singhe file in?

Upendra Wickrema Singhe files trademarks across 2 Nice Classification classes. The most active classes are Class 30 (Staple Foods), Class 42 (Computer & Scientific). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.

What are Upendra Wickrema Singhe's most well-known trademarks?

Upendra Wickrema Singhe's registered trademark portfolio includes well-known marks such as TEVIVE. These are among 1 currently registered trademark in the portfolio.

What is Upendra Wickrema Singhe's trademark registration success rate?

Upendra Wickrema Singhe has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.